Kariuki Enoch 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Kariuki Enoch
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2021-02-09+42,000→ 42,000 totalExercise: $39.47Exp: 2031-02-08→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant.
Signature
/s/ Melissa B. Epperly, Attorney-in-Fact for Enoch Kariuki|2021-02-10